Simulation of the Effects of Co-Locating Naloxone with Automated External Defibrillators

Salerno, Jessica; Weiss, Leon; Salcido, David D

doi:10.1080/10903127.2018.1439128

Prehospital Emergency Care

2018

DOI: 10.1080/10903127.2018.1439128

|View full text |Cite

Simulation of the Effects of Co-Locating Naloxone with Automated External Defibrillators

Jessica Salerno¹,

Leon Weiss²,

David D Salcido³

Abstract: Using these limited methods, co-locating naloxone with AEDs is not likely to have a standalone impact on preventing overdose fatalities.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2021

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study

Winhusen¹,

Walley²,

Fanucchi³

et al. 2020

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Highlights An approach to community implementation of evidence-based practices (EBPs) was needed. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA) was developed. ORCCA outlines: evidence-based strategies, priority populations, community settings. ORCCA is a flexible framework for EBP implementation to reduce opioid-overdose deaths.

show abstract

The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study

Winhusen¹,

Walley²,

Fanucchi³

et al. 2020

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

A review of performance assessment tools for rescuer response in opioid overdose simulations and training programs

Edwards

Mierisch

Mutcheson

et al. 2020

Preventive Medicine Reports

View full text Add to dashboard Cite

Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association

Dezfulian¹,

Orkin²,

Maron³

et al. 2021

Circulation

View full text Add to dashboard Cite

Opioid overdose is the leading cause of death for Americans 25 to 64 years of age, and opioid use disorder affects >2 million Americans. The epidemiology of opioid-associated out-of-hospital cardiac arrest in the United States is changing rapidly, with exponential increases in death resulting from synthetic opioids and linear increases in heroin deaths more than offsetting modest reductions in deaths from prescription opioids. The pathophysiology of polysubstance toxidromes involving opioids, asphyxial death, and prolonged hypoxemia leading to global ischemia (cardiac arrest) differs from that of sudden cardiac arrest. People who use opioids may also develop bacteremia, central nervous system vasculitis and leukoencephalopathy, torsades de pointes, pulmonary vasculopathy, and pulmonary edema. Emergency management of opioid poisoning requires recognition by the lay public or emergency dispatchers, prompt emergency response, and effective ventilation coupled to compressions in the setting of opioid-associated out-of-hospital cardiac arrest. Effective ventilation is challenging to teach, whereas naloxone, an opioid antagonist, can be administered by emergency medical personnel, trained laypeople, and the general public with dispatcher instruction to prevent cardiac arrest. Opioid education and naloxone distributions programs have been developed to teach people who are likely to encounter a person with opioid poisoning how to administer naloxone, deliver high-quality compressions, and perform rescue breathing. Current American Heart Association recommendations call for laypeople and others who cannot reliably establish the presence of a pulse to initiate cardiopulmonary resuscitation in any individual who is unconscious and not breathing normally; if opioid overdose is suspected, naloxone should also be administered. Secondary prevention, including counseling, opioid overdose education with take-home naloxone, and medication for opioid use disorder, is important to prevent recurrent opioid overdose.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Simulation of the Effects of Co-Locating Naloxone with Automated External Defibrillators

Abstract: Using these limited methods, co-locating naloxone with AEDs is not likely to have a standalone impact on preventing overdose fatalities.

Cited by 3 publications

References 8 publications

The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study

The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study

A review of performance assessment tools for rescuer response in opioid overdose simulations and training programs

Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association

Contact Info

Product

Resources

About